KLK3 and prostate cancer: Therefore, the current study provides new assumptions that EV proteins may be involved in other mechanistic pathways distinct from the conventional biomarker (i.e., PSA [34]), which might address the limitation of PSA in prostate cancer diagnosis (Supplementary Figure S2b–d).